Skip to main content

Find Clinical Trials

Home
Conditions
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Clinical trial condition

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Explore clinical trials studying Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma trial results

Enrolling by Invitation

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

NCT07088081

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
Locations: Ain Shams University Cairo, Abbasya, Egypt

View Trial Details

Not Yet Recruiting

Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma

NCT07495735

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +10 more
Locations: Not specified

View Trial Details

Completed

Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

NCT06416683

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +9 more
Locations: CHU de Caen Caen, France/Normandie, France

View Trial Details